__Background__: Premature birth is defined as birth of before 37 completed weeks' gestation. Not all pregnant women showing symptoms of preterm labour will go on to deliver before 37weeks' gestation. Hence, addition of fetal fibronectin (fFN) testing to the diagnostic workup of women with suspected preterm labour may help to identify those women who do not require active management, and thus avoid unnecessary interven
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Aim: To evaluate the clinical management to withhold treatment for preterm labor in symptomatic wome...
Spontaneous preterm birth prior to 37 weeks gestation is a leading cause of neonatal morbidity and m...
Background: Premature birth is defined as birth of before 37 completed weeks' gestation. Not all pre...
Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour
Objective To determine whether the quantitative value of fetal fibronectin (fFN) can predict preterm...
Accurate prediction of preterm birth is a big clinical challenge in obstetrics. Most of the women pr...
Background: Recent data suggest that quantitative measurements of fetal fibronectin can be used accu...
Background: Preterm birth is associated with significant perinatal morbidity and mortality. The feta...
Background: Preterm birth defined as birth before 37 weeks of gestation is a significant public heal...
Objective To evaluate the cost-effectiveness of fetal fibronectin (fFN) versus no-fFN testing to det...
Aim: To evaluate the clinical application of the new Hologic quantitative foetal fibronectin (qfFN) ...
Objective: This study was conducted to evaluate the usefulness of testing for fetal fibronectin (fFN...
OBJECTIVE: To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test in predic...
Preterm birth (PTB) is estimated to account for 6-10% of all births worldwide with 13 million PTBs o...
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Aim: To evaluate the clinical management to withhold treatment for preterm labor in symptomatic wome...
Spontaneous preterm birth prior to 37 weeks gestation is a leading cause of neonatal morbidity and m...
Background: Premature birth is defined as birth of before 37 completed weeks' gestation. Not all pre...
Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour
Objective To determine whether the quantitative value of fetal fibronectin (fFN) can predict preterm...
Accurate prediction of preterm birth is a big clinical challenge in obstetrics. Most of the women pr...
Background: Recent data suggest that quantitative measurements of fetal fibronectin can be used accu...
Background: Preterm birth is associated with significant perinatal morbidity and mortality. The feta...
Background: Preterm birth defined as birth before 37 weeks of gestation is a significant public heal...
Objective To evaluate the cost-effectiveness of fetal fibronectin (fFN) versus no-fFN testing to det...
Aim: To evaluate the clinical application of the new Hologic quantitative foetal fibronectin (qfFN) ...
Objective: This study was conducted to evaluate the usefulness of testing for fetal fibronectin (fFN...
OBJECTIVE: To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test in predic...
Preterm birth (PTB) is estimated to account for 6-10% of all births worldwide with 13 million PTBs o...
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Aim: To evaluate the clinical management to withhold treatment for preterm labor in symptomatic wome...
Spontaneous preterm birth prior to 37 weeks gestation is a leading cause of neonatal morbidity and m...